You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

kinase

Showing 1 - 25 of 7,380
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alopecia Areata Trial in Sohag (Janus Kinase 1 and 2)

Recruiting
  • Alopecia Areata
  • Janus Kinase 1 and 2
  • Sohag, Egypt
    Sohag University hospitals
May 12, 2023

Pantothenate Kinase-Associated Neurodegeneration Trial (Deferiprone)

No longer available
  • Pantothenate Kinase-Associated Neurodegeneration
  • (no location specified)
Nov 9, 2022

Cushing Disease Trial (Fimepinostat)

Not yet recruiting
  • Cushing Disease
  • (no location specified)
Jul 31, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (PEP07)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 1, 2023

Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase

Recruiting
  • Liver Transplant
  • PVHA or TACE
  • Shanghai, Shanghai, China
    The value of tumor feeding vessels deprivation combined with tyr
Nov 26, 2022

Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder

Recruiting
  • Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
  • No intervention; observational
  • Norcross, Georgia
    Center for Rare Neurological Diseases
Oct 20, 2022

Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

Not yet recruiting
  • Tyrosine Kinase Inhibitors
  • Chronic Myeloid Leukemia
  • treatment of TKI in CML
  • Poitiers, France
    Chu Poitiers
Feb 21, 2023

Pancreatic Ductal Adenocarcinoma Trial (combination therapy with no MEKi, combination therapy with MEKi-HCQ, combination therapy

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • combination therapy with no MEKi
  • +3 more
  • (no location specified)
Nov 29, 2022

Liver Tumors Trial in Beijing (Tislelizumab plus tyrosine kinase inhibitor)

Recruiting
  • Liver Neoplasms
  • Tislelizumab plus tyrosine kinase inhibitor
  • Beijing, Beijing, China
    302 Hospital
Sep 22, 2023

Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

Not yet recruiting
  • Preterm Labor
    • (no location specified)
    May 9, 2023

    Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

    Not yet recruiting
    • Liver Transplant; Complications
    • +3 more
    • multi-kinase inhibitors in combination with bevacizumab
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences & Peking Union Medical Colle
    Sep 11, 2023

    Cancer Trial in Changsha (Protein Kinase Inhibitor)

    Recruiting
    • Cancer
    • Protein Kinase Inhibitor
    • Changsha, Hunan, China
      Central South University
    Jun 23, 2022

    Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

    Recruiting
    • Eosinophilic Myeloid Neoplasm
    • Hypereosinophilic Syndrome
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Acute Myeloid Leukemia, Lymphoma, Mantle-Cell Trial (PEP07)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Lymphoma, Mantle-Cell
    • (no location specified)
    Dec 22, 2022

    CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

    Recruiting
    • CML
    • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
    • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
      FUNDALEU
    Jun 29, 2023

    Lung Cancer, NSCLC Trial (Lorlatinib, Cisplatin or Carboplatin, Pemetrexed)

    Not yet recruiting
    • Lung Cancer
    • Non-small Cell Lung Cancer
    • (no location specified)
    Jul 7, 2023

    Ovarian Cancer Trial in San Diego (VS-6063, Paclitaxel, Carboplatin)

    Recruiting
    • Ovarian Cancer
    • San Diego, California
      University of California San Diego
    Feb 1, 2023

    Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in

    Recruiting
    • Breast Cancer
    • CT scans
    • DEXA scan
    • Bronx, New York
      Montefiore Medical Center
    Jan 6, 2023

    Thymidine Kinase 2 Deficiency Trial (MT1621)

    Withdrawn
    • Thymidine Kinase 2 Deficiency
    • (no location specified)
    Aug 16, 2022

    Pyruvate Kinase Deficiency, Pyruvate Kinase Deficiency Anemia, Anemia Trial in Worldwide

    Recruiting
    • Pyruvate Kinase Deficiency
    • +3 more
      • Boston, Massachusetts
      • +4 more
      Aug 5, 2022

      Chronic Kidney Diseases Trial in Durham (Baricitinib, Placebo)

      Recruiting
      • Chronic Kidney Diseases
      • Durham, North Carolina
        Duke Research at Pickett Road
      Dec 15, 2022

      Breast Cancer Trial in Guangzhou (Take probiotics)

      Recruiting
      • Breast Cancer
      • Take probiotics
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Mar 6, 2023

      Idiopathic Inflammatory Myopathies Trial in Beijing (tofacitinib)

      Recruiting
      • Idiopathic Inflammatory Myopathies
      • Beijing, Beijing, China
        Department of Rheumatology and Immunology, Peking University Peo
      Oct 9, 2022

      Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

      Recruiting
      • Neurofibromatosis 1
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      HRQOL in Locally Advanced Thyroid Carcinoma

      Recruiting
      • Thyroid Cancer
      • +2 more
      • Tyrosine kinase inhibitor drugs.
      • Fuzhou, Fujian, China
        Road Fuma No.420
      Apr 11, 2023